| |
| Magyar Sebész Társaság |
|
| Breast and Face Symposia (Budapest, 2012.05.21-22.) |
 Rendezvény kezdete: 2012.05.21. | Rendezvény vége: 2012.05.22. |
| Szakterület(ek): Sebészet, Plasztikai sebészet |
| Helyszín: 1122 Budapest, Ráth György u. 7-9., Országos Onkológiai Intézet Előadóterme |
Az Országos Onkológiai Intézetben (1122 Budapest, Ráth György u. 7-9.) 2012. május 21-22-én "Breast and Face Symposia" címmel tudományos ülést és szakmai továbbképzést szerveznek, az emlősebészetben érdekelt szakorvosok, sebészek plasztikai sebészek és rezidensek számára. Vendég előadók különböző városokból és intézményekből érkeznek: New York, Houston, Róma, Madrid
Online regisztráció: www.convention.hu >>
Tudományos információ:
Dr. Gulyás Gusztáv
gulyas.convention@gmail.com
Szervező:
Papp Zsombor
Convention Budapest Kft.
zspapp@convention.hu
Tel: +36 30 996 7081
A program letölthető ide kattintva >> |
|
|
 |
| |
| Magyar Dermatológiai Társulat |
|
| DHM Digital 2022 - 9th Drug Hypersensitivity Meeting (online, 2022.04.21.) |
| Rendezvény kezdete: 2022.04.21. | Rendezvény vége: 2022.04.21. |
| Helyszín: online |
| A rendezvény Web oldala: https://www.eaaci.org/focused-meetings/dhm-digital-2022 |
9th Drug Hypersensitivity Meeting (DHM) will take place virtually in the EAACI Digital Congress Platform, on April 21, 2022.
This year, DHM will become the perfect platform for our community to have access to the latest and cutting-edge molecular, cellular, and social media tools for allergy diagnosis in alternating theoretical and practical sessions. Participants will learn from experts how to apply these tools and will be presented with the possibility to exchange with peers coming from all over the world.
The scientific programme will include the symposia on virus infection and drug allergy, the mechanism of how viral infection modulates drug allergy, diagnosis of ADR to SARS-CoV-2 vaccines, and more. Some of the scientific highlights of the meeting are:
Biomarkers in DIHS/DRESS
How can viruses induce disruption of drug tolerance
Skin testing with vaccines and components
DHR in HIV patients
New insights into the role of mast cells MRGPRX2
DHM Digital 2022 deadlines to keep in mind:
Early bird registration fee: March 15
Program
Registration |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| DHM Digital 2022 - 9th Drug Hypersensitivity Meeting (online, 2022.04.21.) |
| Rendezvény kezdete: 2022.04.21. | Rendezvény vége: 2022.04.21. |
9th Drug Hypersensitivity Meeting (DHM) will take place virtually in the EAACI Digital Congress Platform, on April 21, 2022.
This year, DHM will become the perfect platform for our community to have access to the latest and cutting-edge molecular, cellular, and social media tools for allergy diagnosis in alternating theoretical and practical sessions. Participants will learn from experts how to apply these tools and will be presented with the possibility to exchange with peers coming from all over the world.
The scientific programme will include the symposia on virus infection and drug allergy, the mechanism of how viral infection modulates drug allergy, diagnosis of ADR to SARS-CoV-2 vaccines, and more. Some of the scientific highlights of the meeting are:
Biomarkers in DIHS/DRESS
How can viruses induce disruption of drug tolerance
Skin testing with vaccines and components
DHR in HIV patients
New insights into the role of mast cells MRGPRX2
DHM Digital 2022 deadlines to keep in mind:
Early bird registration fee: March 15
Program
Registration |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Congress Symposia (Boston, MA, USA, 2022.03.24.) |
| Rendezvény kezdete: 2022.03.24. | Rendezvény vége: 2022.03.24. |
| Helyszín: USA, Boston, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/aad_2022_agenda.htm |
Hot topics in psoriasis: A focus on treatment innovationsAmerican Academy of Dermatology Annual Meeting (AAD) | Boston, MA
Thursday, March 24 | 1:00 – 3:00 pm EDT
Program chair: Craig Leonardi, United States
Program faculty: Andy Blauvelt, United States, and Charles Lynde, Canada
This symposium is supported in part by Abbvie, Eli Lilly and Company, and UCB.
Agenda
WELCOME AND INTRODUCTION Craig Leonardi How to select a systemic treatment for your patient given a palette of at least 13 optionsCraig Leonardi
Innovations in topical treatments for psoriasis
Charles Lynde
Innovations in systemic treatments for psoriasis
Andy Blauvelt
Q & A – Speaker panel
Craig Leonardi
CLOSING AND ADJOURN
Craig Leonardi REGISTER NOW |
|
|
|
|
|
